AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33561756 — intervention group
Group type: EXPERIMENTAL
Intervention: Education plus navigation
Number of subjects: 0
Study 33561756 — intervention group
Group type: COMPARATOR
Intervention: Education
Number of subjects: 0
Study 32307878 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg Sustanon® (testosterone ester injections)
Number of subjects: 19
Study 34291892 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus the m‐Health intervention (Rheumatism Center app)
Number of subjects: 60
Study 34291892 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study 33091917 — intervention group
Group type: EXPERIMENTAL
Intervention: Bandage Contact Lens (BCL)
Number of subjects: 40
Study 33091917 — intervention group
Group type: COMPARATOR
Intervention: Eye Patching
Number of subjects: 40
Study 32653333 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cetirizine 10 mg
Number of subjects: 262
Study 32653333 — intervention group
Group type: COMPARATOR
Intervention: Intravenous diphenhydramine 50 mg
Number of subjects: 262
Study 35482774 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to aerobic exercise prescription (at least two-thirds of the prescribed exercise)
Number of subjects: 0
Study 35482774 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence during week 1 of aerobic exercise
Number of subjects: 0
Study 34582445 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infection
Number of subjects: 4138
Study 34582445 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent pregnancy
Number of subjects: 4138
Study 34582445 — intervention group
Group type: EXPERIMENTAL
Intervention: HSV-2 infection
Number of subjects: 4138
Study 34582445 — intervention group
Group type: EXPERIMENTAL
Intervention: Reported sexual activity
Number of subjects: 4138
Study 34360490 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted cognitive training (RACT)
Number of subjects: 135
Study 34360490 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional cognitive training (TCT)
Number of subjects: 135
Study 34360490 — intervention group
Group type: COMPARATOR
Intervention: No intervention (NI)
Number of subjects: 135
Study 36367979 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithotomy position surgical warmer
Number of subjects: 100
Study 36367979 — intervention group
Group type: COMPARATOR
Intervention: Control group with heated environment, fluid, and upper abdomen
Number of subjects: 100
Study 33666264 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (PC) in addition to traditional care
Number of subjects: 206
Study 33666264 — intervention group
Group type: COMPARATOR
Intervention: Traditional care (Control Arm)
Number of subjects: 206
Study 32590979 — intervention group
Group type: EXPERIMENTAL
Intervention: LDHF/m-mentoring
Number of subjects: 299
Study 32590979 — intervention group
Group type: COMPARATOR
Intervention: TRAD
Number of subjects: 299
Study 35044972 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical natamycin 5% plus CXL
Number of subjects: 111
Study 35044972 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical amphotericin B 0.15% plus CXL
Number of subjects: 111
Study 35044972 — intervention group
Group type: COMPARATOR
Intervention: Topical natamycin 5% alone
Number of subjects: 111
Study 35044972 — intervention group
Group type: COMPARATOR
Intervention: Topical amphotericin B 0.15% alone
Number of subjects: 111
Study 34818273 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin Type A (BTX) intradermal injections to the treated side of the inframammary incision
Number of subjects: 27
Study 34818273 — intervention group
Group type: COMPARATOR
Intervention: Control side (no treatment)
Number of subjects: 27
Study 35017306 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) for acute ischemic stroke (AIS) in patients with active cancer
Number of subjects: 124
Study 35017306 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) for acute ischemic stroke (AIS) in patients with active cancer in a palliative treatment setting
Number of subjects: 124
Study 35017306 — intervention group
Group type: COMPARATOR
Intervention: Endovascular treatment (EVT) for acute ischemic stroke (AIS) in patients without active cancer
Number of subjects: 124
Study 32310691 — intervention group
Group type: EXPERIMENTAL
Intervention: Momiai (500 mg capsules)
Number of subjects: 160
Study 32310691 — intervention group
Group type: COMPARATOR
Intervention: Placebo (500 mg capsules)
Number of subjects: 160
Study 35727801 — intervention group
Group type: EXPERIMENTAL
Intervention: Human coaching
Number of subjects: 0
Study 35727801 — intervention group
Group type: EXPERIMENTAL
Intervention: AI chatbot coaching
Number of subjects: 0
Study 35727801 — intervention group
Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 0
Study 32492040 — intervention group
Group type: EXPERIMENTAL
Intervention: Traumatic hemorrhage patients
Number of subjects: 20207
Study 32492040 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum hemorrhage patients
Number of subjects: 20207
Study 35184324 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication consultation (additional consultation with a physician)
Number of subjects: 408
Study 35184324 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication consultation
Number of subjects: 408
Study 35184324 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 408
Study 34795574 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality-based therapy combined with conventional functional training (1 hour of functional training + 1 hour of virtual reality therapy using Armeo Spring equipment)
Number of subjects: 40
Study 34795574 — intervention group
Group type: COMPARATOR
Intervention: Conventional functional training (2 hours of conventional functional training)
Number of subjects: 40
Study 32682408 — intervention group
Group type: EXPERIMENTAL
Intervention: Support groups for breastfeeding
Number of subjects: 0
Study 32682408 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 34983260 — intervention group
Group type: EXPERIMENTAL
Intervention: TEL-CBT (12 sessions)
Number of subjects: 191
Study 34983260 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 191
Study 34983260 — intervention group
Group type: EXPERIMENTAL
Intervention: NHC
Number of subjects: 191
Study 33337693 — intervention group
Group type: COMPARATOR
Intervention: CHO-only
Number of subjects: 18
Study 33337693 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-PRO
Number of subjects: 18
Study 35612617 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (EG) - 12 sessions of an exercise protocol
Number of subjects: 0
Study 35612617 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication group (MG) - Oral dose of UC-II (1 capsule/day)
Number of subjects: 0
Study 35612617 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - No intervention
Number of subjects: 0
Study 34620904 — intervention group
Group type: EXPERIMENTAL
Intervention: Active mouthwash (APD) - gargling/rinsing 5 times/day until hospital discharge
Number of subjects: 41
Study 34620904 — intervention group
Group type: COMPARATOR
Intervention: Nonactive mouthwash (control) - gargling/rinsing 5 times/day until hospital discharge
Number of subjects: 41
Study 36204964 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital impression combined with all-ceramic denture restoration
Number of subjects: 120
Study 36204964 — intervention group
Group type: COMPARATOR
Intervention: Silicone rubber impression combined with all-ceramic denture restoration
Number of subjects: 120
Study 33530312 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral treatment with 3 g Clostridium butyricum
Number of subjects: 20
Study 33530312 — intervention group
Group type: COMPARATOR
Intervention: No probiotic treatment
Number of subjects: 20
Study 32303745 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 and omega-6 fatty acid serum concentrations
Number of subjects: 200
Study 36153514 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (community-based intervention to increase intergenerational contact)
Number of subjects: 2518
Study 36153514 — intervention group
Group type: COMPARATOR
Intervention: Control group (public health services as usual)
Number of subjects: 2518
Study 33845931 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 0
Study 33845931 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 0
Study 36152791 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided health education (SGHE)
Number of subjects: 0
Study 36152791 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventionist-guided health education (IGHE)
Number of subjects: 0
Study 36152791 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventionist-guided pain coping skills training (CST-PSP)
Number of subjects: 0
Study 36152791 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 35831874 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluralaner (oral dose)
Number of subjects: 28
Study 35831874 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 28
Study 34413142 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine N‐butylbromide (20 mg intravenous injection)
Number of subjects: 25
Study 34413142 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide (4 mg per os)
Number of subjects: 25
Study 34413142 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐4FMFES
Number of subjects: 25
Study 34413142 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐FDG
Number of subjects: 25
Study 34413142 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 18F‐4FMFES and 18F‐FDG
Number of subjects: 25
Study 34413142 — intervention group
Group type: COMPARATOR
Intervention: Comparison of grade 1 and higher-grade tumors
Number of subjects: 25
Study 35141317 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis (4-week group PRP supplemented by two educational sessions for self-hypnosis)
Number of subjects: 0
Study 35141317 — intervention group
Group type: COMPARATOR
Intervention: Relaxation (4-week group PRP supplemented by standard relaxation exercises)
Number of subjects: 0
Study 35141317 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 0
Study 35141317 — intervention group
Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 0
Study 36322475 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissolved tablet (BIC/TAF/FTC 50/200/25 mg)
Number of subjects: 18
Study 36322475 — intervention group
Group type: EXPERIMENTAL
Intervention: Crushed tablet (BIC/TAF/FTC 50/200/25 mg)
Number of subjects: 18
Study 36322475 — intervention group
Group type: COMPARATOR
Intervention: Solid tablet (BIC/TAF/FTC 50/200/25 mg)
Number of subjects: 18
Study 33496795 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide (160 mg daily)
Number of subjects: 71
Study 33496795 — intervention group
Group type: COMPARATOR
Intervention: Bicalutamide (50 mg daily)
Number of subjects: 71
Study 33496795 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide (160 mg daily) among Black patients
Number of subjects: 71
Study 33496795 — intervention group
Group type: COMPARATOR
Intervention: Bicalutamide (50 mg daily) among Black patients
Number of subjects: 71
Study 33496795 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide (160 mg daily) among non-Black patients
Number of subjects: 71
Study 33496795 — intervention group
Group type: COMPARATOR
Intervention: Bicalutamide (50 mg daily) among non-Black patients
Number of subjects: 71
Study 32112428 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin 5% cream (treatment group)
Number of subjects: 70
Study 32112428 — intervention group
Group type: COMPARATOR
Intervention: Plain petri dishes (control group)
Number of subjects: 70
Study 32112428 — intervention group
Group type: COMPARATOR
Intervention: Observational study (30 scabies mites)
Number of subjects: 70
Study 34599979 — intervention group
Group type: EXPERIMENTAL
Intervention: Benralizumab 30 mg every 4 weeks for the first 3 doses, then every 8 weeks thereafter
Number of subjects: 413
Study 34599979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 413
Study 32871885 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical Thinking Intervention (CTI)
Number of subjects: 44
Study 32871885 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control Group
Number of subjects: 44
Study 35179608 — intervention group
Group type: COMPARATOR
Intervention: Manual trigger point pressure release
Number of subjects: 50
Study 33964405 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal ozone infiltration (plus foraminal infiltration of ozone, steroids, and anesthetic)
Number of subjects: 0
Study 33964405 — intervention group
Group type: COMPARATOR
Intervention: Intradiscal oxygen infiltration (plus foraminal infiltration of oxygen, steroids, and anesthetic)
Number of subjects: 0
Study 33964405 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study 33964405 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal ozone infiltration
Number of subjects: 0
Study 32299068 — intervention group
Group type: EXPERIMENTAL
Intervention: RCMFE of the CP signal in glaucomatous eyes
Number of subjects: 58
Study 32299068 — intervention group
Group type: COMPARATOR
Intervention: RCMFE of the CP signal
Number of subjects: 58
Study 32299068 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal scale for RCMFE
Number of subjects: 58
Study 32299068 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic analysis for optimal scale
Number of subjects: 58
Study 35260800 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 1762
Study 33934120 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to Occupational Performance (CO‐OP) intervention
Number of subjects: 78
Study 33934120 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 78
Study 35118746 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific Thematic Nursing Care Action Modules (STNC‐AM)
Number of subjects: 44
Study 35118746 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study 32893100 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape
Number of subjects: 44
Study 32893100 — intervention group
Group type: COMPARATOR
Intervention: Sham tape
Number of subjects: 44
Study 32893100 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol (cockup orthosis and lumbrical stretching exercises)
Number of subjects: 44
Study 36494919 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS
Number of subjects: 17
Study 34058081 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg dipyrone
Number of subjects: 260
Study 34058081 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg tilidine/naloxone
Number of subjects: 260
Study 34058081 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg tilidine/naloxone
Number of subjects: 260
Study 34058081 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 260
Study 32746736 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga meditation program (YoMed)
Number of subjects: 33
Study 32746736 — intervention group
Group type: COMPARATOR
Intervention: Established proprioceptive training program (PRO)
Number of subjects: 33
Study 33052906 — intervention group
Group type: EXPERIMENTAL
Intervention: Competitive gamification intervention
Number of subjects: 602
Study 33052906 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive gamification intervention
Number of subjects: 602
Study 33052906 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative gamification intervention
Number of subjects: 602
Study 33052906 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 602
Study 32804602 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace Health Promotion Program (WHPP)
Number of subjects: 30
Study 32804602 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 32050899 — intervention group
Group type: EXPERIMENTAL
Intervention: G-MEDSS intervention (Computerised Clinical Decision Support System)
Number of subjects: 0
Study 32050899 — intervention group
Group type: COMPARATOR
Intervention: Usual care HMR service (without G-MEDSS)
Number of subjects: 0
Study 36180151 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercises for 6 weeks
Number of subjects: 21
Study 36180151 — intervention group
Group type: COMPARATOR
Intervention: Usual antenatal care (control)
Number of subjects: 21
Study 36180151 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercises
Number of subjects: 21
Study 34627156 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based teaching
Number of subjects: 153
Study 34627156 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based teaching
Number of subjects: 153
Study 34627156 — intervention group
Group type: COMPARATOR
Intervention: Lecture-based teaching (control)
Number of subjects: 153
Study 34935067 — intervention group
Group type: COMPARATOR
Intervention: Locator
Number of subjects: 17
Study 34935067 — intervention group
Group type: EXPERIMENTAL
Intervention: CM LOC
Number of subjects: 17
Study 34935067 — intervention group
Group type: EXPERIMENTAL
Intervention: PEKK
Number of subjects: 17
Study 33630448 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-port laparoscopic colectomy (MPC)
Number of subjects: 200
Study 33630448 — intervention group
Group type: COMPARATOR
Intervention: Single-incision laparoscopic colectomy (SILC)
Number of subjects: 200
Study 35588245 — intervention group
Group type: EXPERIMENTAL
Intervention: Viloxazine extended-release (600 mg/d)
Number of subjects: 439
Study 35588245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 439
Study 33648496 — intervention group
Group type: EXPERIMENTAL
Intervention: ICF training programme (one day's training in interprofessional practice)
Number of subjects: 203
Study 33648496 — intervention group
Group type: COMPARATOR
Intervention: Short talk on interprofessional practice (control group)
Number of subjects: 203
Study 35654318 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (LT)
Number of subjects: 59
Study 32701452 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep belief network (DBN) for classification
Number of subjects: 0
Study 32701452 — intervention group
Group type: EXPERIMENTAL
Intervention: Stacked denoising autoencoder (SDA) for reconstruction of handwritten digits
Number of subjects: 0
Study 32768465 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (initial dose 0.10 mg/kg/d, median maximal dose 0.38 mg/kg/d)
Number of subjects: 230
Study 32768465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study 32768465 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 230
Study 35019882 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga exercise program (one hour twice weekly for 12 weeks)
Number of subjects: 48
Study 35019882 — intervention group
Group type: COMPARATOR
Intervention: Patient education program (for both groups)
Number of subjects: 48
Study 34814768 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm water plus ginger (GI)
Number of subjects: 36
Study 34814768 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm water plus mustard (MU)
Number of subjects: 36
Study 34814768 — intervention group
Group type: COMPARATOR
Intervention: Warm water only (WA)
Number of subjects: 36
Study 34814768 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin temperature measurements (face, hands, feet)
Number of subjects: 36
Study 35881199 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (SH) eyedrops, applied 4 times daily for 2 months
Number of subjects: 78
Study 35881199 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi‐fluorinated alkane (SFA) eyedrops, applied 4 times daily for 2 months
Number of subjects: 78
Study 35881199 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-smokers)
Number of subjects: 78
Study 34362491 — intervention group
Group type: EXPERIMENTAL
Intervention: HOTAIRM1 siRNA group
Number of subjects: 0
Study 34362491 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34362491 — intervention group
Group type: COMPARATOR
Intervention: HOTAIRM1 siRNA-NC group
Number of subjects: 0
Study 33068876 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 43
Study 33068876 — intervention group
Group type: EXPERIMENTAL
Intervention: siRNA depletion in a human trophoblast cell line model
Number of subjects: 43
Study 33068876 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 43
Study 33190178 — intervention group
Group type: EXPERIMENTAL
Intervention: TRUST intervention
Number of subjects: 200
Study 33190178 — intervention group
Group type: COMPARATOR
Intervention: Time and attention control
Number of subjects: 200
Study 36564573 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcision combined with cross-linked HA filler injection
Number of subjects: 40
Study 36564573 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcision followed by fractional CO2 laser
Number of subjects: 40
Study 36564573 — intervention group
Group type: COMPARATOR
Intervention: Subcision only (control group)
Number of subjects: 40
Study 32144616 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT self-help
Number of subjects: 24
Study 32144616 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced self-help (ACT self-help with telephone support)
Number of subjects: 24
Study 32144616 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 24
Study 33539400 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Administered therapy (SAT)
Number of subjects: 252
Study 33539400 — intervention group
Group type: COMPARATOR
Intervention: Directly Observed Therapy (DOT)
Number of subjects: 252
Study 32320027 — intervention group
Group type: EXPERIMENTAL
Intervention: Clascoterone cream, 1%
Number of subjects: 1440
Study 32320027 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 1440
Study 36165956 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic acupuncture associated with pelvic floor muscle training
Number of subjects: 64
Study 36165956 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor muscle training only
Number of subjects: 64